160 related articles for article (PubMed ID: 2585773)
21. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
[TBL] [Abstract][Full Text] [Related]
22. Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation.
Kamarashev J; Theler B; Dummer R; Burg G
Int J Dermatol; 2007 Sep; 46(9):930-5. PubMed ID: 17822495
[TBL] [Abstract][Full Text] [Related]
23. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
24. Folliculotropic mycosis fungoides: an aggressive variant of cutaneous T-cell lymphoma.
Gerami P; Rosen S; Kuzel T; Boone SL; Guitart J
Arch Dermatol; 2008 Jun; 144(6):738-46. PubMed ID: 18559762
[TBL] [Abstract][Full Text] [Related]
25. A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides.
Kaye FJ; Bunn PA; Steinberg SM; Stocker JL; Ihde DC; Fischmann AB; Glatstein EJ; Schechter GP; Phelps RM; Foss FM
N Engl J Med; 1989 Dec; 321(26):1784-90. PubMed ID: 2594037
[TBL] [Abstract][Full Text] [Related]
26. [Primary cutaneous lymphoma--mycosis fungoides].
Nagatani T; Okazawa H; Mizuno H; Yanagi N; Miyazawa M; Baba N
Gan To Kagaku Ryoho; 1997 Jan; 24(1):23-9. PubMed ID: 9020941
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of narrowband UVB vs. PUVA in patients with early-stage mycosis fungoides.
Ponte P; Serrão V; Apetato M
J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):716-21. PubMed ID: 19929938
[TBL] [Abstract][Full Text] [Related]
28. Expression of cytotoxic proteins by neoplastic T cells in mycosis fungoides increases with progression from plaque stage to tumor stage disease.
Vermeer MH; Geelen FA; Kummer JA; Meijer CJ; Willemze R
Am J Pathol; 1999 Apr; 154(4):1203-10. PubMed ID: 10233858
[TBL] [Abstract][Full Text] [Related]
29. Difference in prognosis between T- and B-cell lymphomas: clinical study at Shikoku Cancer Center Hospital.
Toki H; Okabe K; Kimura Y; Yumoto Y; Morita M; Ogushi I; Koike S; Takashima S; Sato G; Moriwaki S
Jpn J Clin Oncol; 1986 Mar; 16(1):41-8. PubMed ID: 3486301
[TBL] [Abstract][Full Text] [Related]
30. Immunopathology of cutaneous T-cell lymphomas.
Nasu K; Said J; Vonderheid E; Olerud J; Sako D; Kadin M
Am J Pathol; 1985 Jun; 119(3):436-47. PubMed ID: 3893149
[TBL] [Abstract][Full Text] [Related]
31. Mycosis fungoides and the Sézary syndrome.
Kim YH; Hoppe RT
Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
[TBL] [Abstract][Full Text] [Related]
32. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
33. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
34. [ATL (adult T-cell leukemia/lymphoma)].
Ichimaru M; Tsukazaki K; Ikeda S
Rinsho Ketsueki; 1989 Aug; 30(8):1208-11. PubMed ID: 2601035
[TBL] [Abstract][Full Text] [Related]
35. Immunohistochemical staining for CD45R isoforms in paraffin sections to diagnose mycosis fungoides-type cutaneous T-cell lymphoma.
Ismail SA; Han R; Sanborn SL; Stevens SR; Cooper KD; Wood GS; Gilliam AC
J Am Acad Dermatol; 2007 Apr; 56(4):635-42. PubMed ID: 17367612
[TBL] [Abstract][Full Text] [Related]
36. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
Moore PF; Olivry T; Naydan D
Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
[TBL] [Abstract][Full Text] [Related]
37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
38. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of four cases of B-cell lymphoma].
Kuroki Y; Tada S; Kitamura T; Kawana N; Ogata K; Idemori M; Inoue S
Nihon Hifuka Gakkai Zasshi; 1990 Jan; 100(1):71-84. PubMed ID: 2191158
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
